NCT00135993View on ClinicalTrials.gov

Four Different Transdermal Doses of Rotigotine in Subjects With Idiopathic Restless Legs Syndrome

PHASE3CompletedINTERVENTIONAL
Enrollment

811

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

November 30, 2006

Study Completion Date

November 30, 2006

Conditions
Restless Legs Syndrome
Interventions
DRUG

Rotigotine

Trial Locations (1)

Unknown

Schwarz, RTP

Sponsors

Lead Sponsor

UCB Pharma
All Listed Sponsors
lead

UCB Pharma

INDUSTRY